Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications
ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
|3||Not yet recruiting||
Saxagliptin and Acute Myocardial Infarction:Effects on Platelet Function
† Study has passed its completion date and status has not been verified in more than two years.